Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-04 5:34 pm Purchase |
2024-09-24 | 13G | Pliant Therapeutics, Inc. PLRX |
Paradigm BioCapital Advisors LP | 3,059,411 5.030% |
3,059,411 (New Position) |
Filing History |
| 2024-05-02 4:34 pm Purchase |
2024-04-22 | 13G | Kura Oncology, Inc. KURA |
Paradigm BioCapital Advisors LP | 3,861,318 5.100% |
3,861,318 (New Position) |
Filing History |
| 2024-04-08 5:09 pm Purchase |
2024-03-27 | 13G | Y-mAbs Therapeutics, Inc. YMAB |
Paradigm BioCapital Advisors LP | 2,198,312 5.020% |
2,198,312 (New Position) |
Filing History |
| 2024-02-14 5:57 pm Purchase |
2023-12-31 | 13G | Arcellx, Inc. ACLX |
Paradigm BioCapital Advisors LP | 3,658,624 7.000% |
1,235,924 (+51.01%) |
Filing History |
| 2024-02-14 4:08 pm Purchase |
2023-12-31 | 13G | Ambrx Biopharma Inc. AMAM |
Paradigm BioCapital Advisors LP | 4,502,689 7.100% |
4,502,689 (New Position) |
Filing History |
| 2024-02-14 4:08 pm Purchase |
2023-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN |
Paradigm BioCapital Advisors LP | 3,176,743 5.500% |
859,109 (+37.07%) |
Filing History |
| 2024-02-14 4:08 pm Purchase |
2023-12-31 | 13G | Autolus Therapeutics plc AUTL |
Paradigm BioCapital Advisors LP | 12,611,335 7.200% |
2,512,751 (+24.88%) |
Filing History |
| 2024-02-14 4:08 pm Purchase |
2023-12-31 | 13G | Bicycle Therapeutics plc BCYC |
Paradigm BioCapital Advisors LP | 3,707,001 9.800% |
2,096,336 (+130.15%) |
Filing History |
| 2024-02-14 4:08 pm Purchase |
2023-12-31 | 13G | Disc Medicine, Inc. IRON |
Paradigm BioCapital Advisors LP | 2,385,857 9.900% |
1,149,939 (+93.04%) |
Filing History |
| 2024-02-14 4:08 pm Purchase |
2023-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
Paradigm BioCapital Advisors LP | 5,304,313 9.990% |
2,993,615 (+129.55%) |
Filing History |
| 2024-02-14 4:08 pm Sale |
2023-12-31 | 13G | Vor Biopharma Inc. VOR |
Paradigm BioCapital Advisors LP | 6,457,293 9.500% |
-20,706 (-0.32%) |
Filing History |
| 2024-02-14 4:08 pm Purchase |
2023-12-31 | 13G | Nuvalent, Inc. NUVL |
Paradigm BioCapital Advisors LP | 3,858,008 6.700% |
478,928 (+14.17%) |
Filing History |
| 2024-02-14 4:08 pm Purchase |
2023-12-31 | 13G | Olema Pharmaceuticals, Inc. OLMA |
Paradigm BioCapital Advisors LP | 7,903,600 14.300% |
100,000 (+1.28%) |
Filing History |
| 2024-02-14 4:08 pm Unchanged |
2023-12-31 | 13G | COMPASS Pathways plc CMPS |
Paradigm BioCapital Advisors LP | 3,425,988 5.400% |
0 (Unchanged) |
Filing History |
| 2024-02-14 4:08 pm Sale |
2024-01-26 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP |
Paradigm BioCapital Advisors LP | 0 0.000% |
-399,658 (Position Closed) |
Filing History |
| 2024-02-05 4:21 pm Purchase |
2024-01-26 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP |
Paradigm BioCapital Advisors LP | 399,658 9.000% |
399,658 (New Position) |
Filing History |
| 2024-01-22 5:05 pm Purchase |
2024-01-12 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
Paradigm BioCapital Advisors LP | 1,927,506 5.800% |
1,927,506 (New Position) |
Filing History |
| 2024-01-02 5:20 pm Purchase |
2023-12-20 | 13G | COMPASS Pathways plc CMPS |
Paradigm BioCapital Advisors LP | 3,425,988 5.400% |
3,425,988 (New Position) |
Filing History |
| 2023-10-30 5:12 pm Purchase |
2023-10-19 | 13G | Nuvalent, Inc. NUVL |
Paradigm BioCapital Advisors LP | 3,379,080 5.900% |
3,379,080 (New Position) |
Filing History |
| 2023-09-25 5:24 pm Purchase |
2023-09-14 | 13G | Ambrx Biopharma Inc. AMAM |
Paradigm BioCapital Advisors LP | 25,172,784 5.700% |
25,172,784 (New Position) |
Filing History |